SCHEMBL918101

SCHEMBL918101

O=S(=O)(O)CCC[n+]1ccc(-c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PABPC1 P11940 1/20 0.47
EIF4H Q15056 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
CHRNA7 P36544 4/20 0.41
CHRNA10 Q9GZZ6 4/20 0.41
CHRNA9 Q9UGM1 4/20 0.41
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
BCHE P06276 6/20 0.39
ACHE P22303 5/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19968566 0.93 MEN1 (0.45) PABPC1EIF4HCTDSP1CHRNA7CHRNA10
SCHEMBL30218182 0.91 MEN1 (0.44) PABPC1EIF4HCTDSP1CHRNA7CHRNA10
SCHEMBL19961822 0.84 MEN1 (0.56) PABPC1EIF4HCTDSP1CHRNA7CHRNA10
SCHEMBL19961817 0.84 MEN1 (0.43) PABPC1EIF4HCTDSP1CHRNA7CHRNA10
SCHEMBL19961819 0.83 KMT2A (0.65) MEN1TP53CYP1A2CYP2D6MAPT
SCHEMBL9173625 0.83 PABPC1 (0.45) PABPC1EIF4HCTDSP1MEN1MAPT
SCHEMBL351087 0.83 BCHE (0.52) BCHEACHE
SCHEMBL17157364 0.82 PABPC1 (0.69) PABPC1EIF4HCTDSP1CHRNA7CHRNA10
SCHEMBL10231106 0.81 PABPC1 (0.44) PABPC1EIF4HCTDSP1CHRNA7CHRNA10
Water SCHEMBL1254758 0.81 BCHE (0.50) BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9772552-B2 Thiosulfate polymer compositions and articles EASTMAN KODAK COMPANY (US) 2017-09-26 US disclosed
US-9772552-B2 Thiosulfate polymer compositions and articles EASTMAN KODAK COMPANY (US) 2017-09-26 US disclosed
US-9709889-B2 Forming conductive metal patterns using thiosulfate copolymers EASTMAN KODAK COMPANY (US) 2017-07-18 US disclosed
US-9709889-B2 Forming conductive metal patterns using thiosulfate copolymers EASTMAN KODAK COMPANY (US) 2017-07-18 US disclosed
US-20160147148-A1 FORMING CONDUCTIVE METAL PATTERNS USING THIOSULFATE COPOLYMERS BANK OF AMERICA, N.A., AS AGENT 2016-05-26 US disclosed
US-20160147148-A1 FORMING CONDUCTIVE METAL PATTERNS USING THIOSULFATE COPOLYMERS BANK OF AMERICA, N.A., AS AGENT 2016-05-26 US disclosed
US-8986924-B2 Method of sequestering metals using thiosulfate polymers EASTMAN KODAK COMPANY (US) 2015-03-24 US disclosed
US-8986924-B2 Method of sequestering metals using thiosulfate polymers EASTMAN KODAK COMPANY (US) 2015-03-24 US disclosed
US-8916336-B2 Patterning method using thiosulfate polymer and metal nanoparticles EASTMAN KODAK COMPANY (US) 2014-12-23 US disclosed
US-20140287349-A1 THIOSULFATE POLYMER COMPOSITIONS AND ARTICLES BANK OF AMERICA, N.A., AS AGENT 2014-09-25 US disclosed
US-20140287366-A1 METHOD OF SEQUESTERING METALS USING THIOSULFATE POLYMERS BANK OF AMERICA, N.A., AS AGENT 2014-09-25 US disclosed
EP-1646659-B1 METHOD FOR THE PREPARATION OF 1,3-PROPANE DISULFONIC ACID COMPOUNDS KIACTA S RL (CH) 2014-05-14 EP disclosed
US-20110021813-A1 PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF KONG XIANQI 2011-01-27 US disclosed
US-7829613-B2 Azinium salts as splayant for layered materials EASTMAN KODAK COMPANY (US) 2010-11-09 US disclosed
US-7632879-B2 Azinium salts as splayant for layered materials EASTMAN KODAK COMPANY (US) 2009-12-15 US disclosed
US-7632879-B2 Azinium salts as splayant for layered materials EASTMAN KODAK COMPANY (US) 2009-12-15 US disclosed
US-20090176111-A1 AZINIUM SALTS AS SPLAYANT FOR LAYERED MATERIALS LASER PACIFIC MEDIA CORPORATION 2009-07-09 US disclosed
US-20080027097-A1 PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2008-01-31 US disclosed
US-7253306-B2 Pharmaceutical drug candidates and methods for preparation thereof NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2007-08-07 US disclosed
US-20050143462-A1 Pharmaceutical drug candidates and methods for preparation thereof NEUROCHEM (INTERNATIONAL) LIMITED (CH) 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021813-A1 PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF MPST, TTR, STS PABPC1 308/4885EIF4H 2578/4885CTDSP1 2285/4885
US-20050143462-A1 Pharmaceutical drug candidates and methods for preparation thereof MPST, TTR, STS PABPC1 308/4885EIF4H 2578/4885CTDSP1 2285/4885
US-20080027097-A1 PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF MPST, TTR, STS PABPC1 308/4885EIF4H 2578/4885CTDSP1 2285/4885
US-20090176111-A1 AZINIUM SALTS AS SPLAYANT FOR LAYERED MATERIALS NUDT15, NUDT5, ALKBH5 PABPC1 346/4885EIF4H 3022/4885CTDSP1 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.